CI241227P327500
- 0.00
- 0.000.00%
Cigna Group Newsroom
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Santa Claus Came Without Rallying the Troops | Live Stock
Are The Cigna Group's (NYSE:CI) Mixed Financials Driving The Negative Sentiment?
Lighthouse Recovery in Dallas Now Accepting Cigna Insurance for Addiction and Mental Health Treatment
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Weekly Buzz: So far, Santa is Letting us Down
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
Top Dividend Picks for 2025 According to Seeking Alpha's Quant Metrics
Dongbei Securities: Initiates a "Buy" rating on EDIANYUN as signs of a turnaround in IT service performance are starting to emerge.
Northeast Securities released a research report stating that it has initiated coverage on EDIANYUN (02416) with a "Buy" rating. The firm expects that during this economic cycle, an increasing number of small and medium-sized enterprises will enhance their risk resistance by leasing equipment from office equipment suppliers. The company's performance is expected to continue growing, with projected revenues of 1.336/1.604/2.13 billion yuan and net income of 0.047/0.148/0.267 billion yuan for 2024-2026. The main points of the report are as follows: the company provides on-demand office IT integrated solutions and other services through cloud-based office.
P/E Ratio Insights for Cigna
Mizuho Securities Maintains Cigna Group(CI.US) With Buy Rating, Announces Target Price $360
Looking Into Cigna's Recent Short Interest
Mizuho Adjusts Price Target on Cigna Group to $360 From $385, Keeps Outperform Rating
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
The Returns At Cigna Group (NYSE:CI) Aren't Growing
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
U.S. Healthcare Spending Climbs 7.5% in 2023
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Cigna (CI) Soars 6.3%: Is Further Upside Left in the Stock?